Food News and Research

RSS

IFR scientists mine the genome of C. botulinum to reveal new information about toxin genes

The toxin that causes botulism is the most potent that we know of. Eating an amount of toxin just 1000th the weight of a grain of salt can be fatal, which is why so much effort has been put into keeping Clostridium botulinum, which produces the toxin, out of our food.

15 May 2013

Roundup: Ore. Health Co-Ops to compete with big insurers; Texas lawmakers find money for mental health, women's care

Armed with hefty federal loans, two startup health insurers are jumping into a crowded and confusing Oregon market just as the biggest changes to U.S. health care in generations roll out this fall.

15 May 2013

New nimodipine oral solution receives FDA approval for subarachnoid hemorrhage treatment

On May 10, the U.S. Food and Drug Administration approved Nymalize, a new nimodipine oral solution, to treat patients experiencing symptoms resulting from ruptured blood vessels in the brain (subarachnoid hemorrhage).

15 May 2013

Synthetic silicate nanoplatelets can stimulate stem cells to become bone cells

In new research published online May 13, 2013 in Advanced Materials, researchers from Brigham and Women's Hospital are the first to report that synthetic silicate nanoplatelets (also known as layered clay) can induce stem cells to become bone cells without the need of additional bone-inducing factors.

15 May 2013

FDA OKs TWi Pharmaceuticals' tentative ANDA for Guanfacine Hydrochloride Extended Release Tablets

TWi Pharmaceuticals, Inc. today announced that it has received tentative approval for its Abbreviated New Drug Application for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration.

14 May 2013

First Edition: May 14, 2013

Today's headlines include reports about an Obama administration plan to delay Medicaid DSH payment reductions.

14 May 2013

Renaissance in drug development for rare diseases

Once famously described as "orphan diseases, too small to be noticed, too small to be funded" in the Hollywood drama Lorenzo's Oil, rare diseases are getting unprecedented attention today among drug manufacturers, who are ramping up research efforts and marketing new medicines that promise fuller lives for children and other patients with these heartbreaking conditions.

14 May 2013

All restaurants need to provide consumers with nutritional content of products, new study suggests

As the restaurant industry prepares to implement new rules requiring chains with 20 or more locations to post calorie content information, the results of a new study suggest that it would be beneficial to public health for all restaurants to provide consumers with the nutritional content of their products.

14 May 2013

Research may help scientists learn anti-aging secrets of sacred lotus

A team of 70 scientists from the U.S., China, Australia and Japan today reports having sequenced and annotated the genome of the "sacred lotus," which is believed to have a powerful genetic system that repairs genetic defects, and may hold secrets about aging successfully.

14 May 2013

Processed and fast food salt levels remain high as ever, new study reports

The dangerously high salt levels in processed food and fast food remain essentially unchanged, despite numerous calls from public and private health agencies for the food industry to voluntarily reduce sodium levels, reports a new Northwestern Medicine study conducted with the Center for Science in the Public Interest.

14 May 2013

Research findings may pave way to new treatment for Alzheimer's disease in humans

A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment.

14 May 2013

Roundup: NYC examines solitary confinement alternatives for mentally ill inmates; Texas lawmakers push to modernize medical practices; N.C. cancer parity bill passes House

New York City will soon change the way mentally ill inmates are disciplined after breaking rules while in jail, creating alternatives to the more traditional approach of solitary confinement used for most inmates (Yee, 5/12).

14 May 2013

FDA approves Arbor Pharmaceuticals' NDA for Nymalize oral solution

Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration has approved its New Drug Application for Nymalize (nimodipine) oral solution.

14 May 2013

Understanding different forms of hepatitis

It's Hepatitis Awareness Month. Understanding the different forms of hepatitis, who is at risk and how it can be prevented and treated can be confusing.

14 May 2013

Food Defense Plan Builder: FDA's new tool to help food industry craft defense measures

The U.S. Food and Drug Administration has released a new tool to help bolster the food industry's defense measures against an act of intentional food contamination.

14 May 2013

University of Liverpool researchers develop smart phone app that promotes weight loss

Researchers at the University of Liverpool have developed a smart phone app that helps users lose weight by carefully recording their food consumption.

14 May 2013

FDA grants priority review for Janssen's simeprevir

Medivir AB today announces that the U.S. Food and Drug Administration has granted Priority Review to the New Drug Application by Janssen for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease.

14 May 2013

Food News and Research

IFR scientists mine the genome of C. botulinum to reveal new information about toxin genes

Roundup: Ore. Health Co-Ops to compete with big insurers; Texas lawmakers find money for mental health, women's care

New nimodipine oral solution receives FDA approval for subarachnoid hemorrhage treatment

Synthetic silicate nanoplatelets can stimulate stem cells to become bone cells

FDA OKs TWi Pharmaceuticals' tentative ANDA for Guanfacine Hydrochloride Extended Release Tablets

First Edition: May 14, 2013

Renaissance in drug development for rare diseases

All restaurants need to provide consumers with nutritional content of products, new study suggests

Research may help scientists learn anti-aging secrets of sacred lotus

Processed and fast food salt levels remain high as ever, new study reports

Research findings may pave way to new treatment for Alzheimer's disease in humans

Roundup: NYC examines solitary confinement alternatives for mentally ill inmates; Texas lawmakers push to modernize medical practices; N.C. cancer parity bill passes House

FDA approves Arbor Pharmaceuticals' NDA for Nymalize oral solution

Understanding different forms of hepatitis

Food Defense Plan Builder: FDA's new tool to help food industry craft defense measures

University of Liverpool researchers develop smart phone app that promotes weight loss

FDA grants priority review for Janssen's simeprevir

Biogen Idec announces FDA's acceptance of ELOCTATE BLA for treatment of hemophilia A

Senate bill on FDA oversight of compounding pharmacies gets broad backing as hearings move closer

Researchers identify clue to explain the reversible memory loss caused by statins

Understanding cultivated meat and its global potential eBook

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Latest News